Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 281.5 TWD -1.23% Market Closed
Market Cap: 74.7B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Lotus Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lotus Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1720

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Income
NT$4.5B
CAGR 3-Years
27%
CAGR 5-Years
38%
CAGR 10-Years
55%
Y
YungShin Global Holding Corp
TWSE:3705
Operating Income
NT$1.1B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
Formosa Laboratories Inc
TWSE:4746
Operating Income
NT$737.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Income
NT$442.1m
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
S
SCI Pharmtech Inc
TWSE:4119
Operating Income
NT$145.3m
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-5%
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Income
NT$1.3B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
16%

See Also

What is Lotus Pharmaceutical Co Ltd's Operating Income?
Operating Income
4.5B TWD

Based on the financial report for Jun 30, 2024, Lotus Pharmaceutical Co Ltd's Operating Income amounts to 4.5B TWD.

What is Lotus Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
55%

Over the last year, the Operating Income growth was -28%. The average annual Operating Income growth rates for Lotus Pharmaceutical Co Ltd have been 27% over the past three years , 38% over the past five years , and 55% over the past ten years .

Back to Top